Results 191 to 200 of about 510,863 (314)
Daratumumab monotherapy in a patient with kappa light chain multiple myeloma and decompensated cirrhosis: a case report. [PDF]
Yang X +5 more
europepmc +1 more source
Foxc1 regulates Pecam-1 Expression in embryonic Endothelial Progenitor Cells [PDF]
Lamparter, Mathias
core
Genetic and pharmacological inhibition of SLC11A1 functioning as an H+/Fe2+ antiporter–mediated lysosomal iron accumulation in microglia promotes lysosomal lumen acidification, increases CTSD expression, enhances lysosomal myelin debris uptake and degradation, and promotes repair following white matter stroke. ABSTRACT White matter stroke (WMS) results
Lingling Qiu +11 more
wiley +1 more source
Headache as the initial symptom in two cases of multiple myeloma: a case report and literature review. [PDF]
Liu D, Du M, Gao X.
europepmc +1 more source
Notch2 Directs aTreg Cell Fate toward Immunoregulation or Inflammatory Pyroptosis
Schematic illustration showing that the Notch2 intracellular domain (NICD2) facilitates pyroptosis resistance in activated Tregs through the RREB1/Foxo1 signaling pathway. In addition, Notch2‐mediated pyroptosis resistance in activated Tregs promotes immunoregulatory capacity, thereby attenuating Th2‐driven inflammatory responses in allergic rhinitis ...
Yue‐Long Qiao +10 more
wiley +1 more source
POEMS syndrome complicated by portal hypertension resembling decompensated cirrhosis: a case report and diagnostic insights. [PDF]
Zhou H +7 more
europepmc +1 more source
[Paper electrophoresis of blood proteins; preliminary results].
V, PERISIC, M, RASTIC
openaire +1 more source
ARID1A, a SWI/SNF complex component, is frequently mutated in colorectal cancer (CRC). CRC with ARID1A/TP53 concurrent mutations shows marked sensitivity to WEE1 inhibition. ARID1A loss induces R‐loop‐mediated replication stress, impairs ATF3 transcription, and amplifies WEE1i‐induced DNA damage, suggesting a promising therapeutic vulnerability ...
Chi Zhang +17 more
wiley +1 more source
Comparison of Two Strategies of Analysis of Urinary Protein Composition for the Diagnosis and Follow-Up of Renal Diseases. [PDF]
Guyon J +8 more
europepmc +1 more source
In this work, we showcased two significant scientific advances in (i) developing a portable biosensor technology for rapid decentralized prostate cancer urinary biomarker testing and reporting, with superior performance to current clinical testing practice; and (ii) proposing a clinical validation framework (for our biosensor development) which can be ...
Kevin M. Koo +14 more
wiley +1 more source

